NLRP3 and polycystic ovary syndrome: Additionally, a comparison of NLRP3 expression levels between the control group and the PCOS group with a BMI < 25 kg/m2 Post-treatment revealed a significantly higher expression in the control group (P = 0.013) (Fig 4D).